Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage

Figure 8

(a) Pictures of LUSC tumors in shVRK1-transfected, shNC-transfected DOX and shVRK1 + DOX groups of mice at 28 days and their (b) volume change graphs; (c) LUSC tumor weights in shVRK1-transfected, shNC-transfected DOX, and shVRK1 + DOX groups of mice at 28 days; (d) apoptosis of LUSC tumor cells in shVRK1-transfected, shNC-transfected DOX, and shVRK1 + DOX groups of mice at 28 days and (e) their quantification graphs with (f) microscopic observation.

(a)

(b)

(c)

(d)

(e)

(f)